PubRank

Lieven Stuyver

Author PubWeight™ 16.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing. J Infect Dis 2012 1.09
2 CXCR4-using HIV type 1 variants are more commonly found in peripheral blood mononuclear cell DNA than in plasma RNA. J Acquir Immune Defic Syndr 2009 1.08
3 Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 2006 1.06
4 Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters. J Acquir Immune Defic Syndr 2008 1.05
5 Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients. J Clin Virol 2006 1.03
6 Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG. Gastroenterology 2011 1.03
7 DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants. Antimicrob Agents Chemother 2002 1.01
8 Comparison of the FilmArray RP, Verigene RV+, and Prodesse ProFLU+/FAST+ multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium. J Clin Microbiol 2013 1.00
9 A pragmatic approach to HIV-1 drug resistance determination in resource-limited settings by use of a novel genotyping assay targeting the reverse transcriptase-encoding region only. J Clin Microbiol 2013 0.93
10 Development of a real-time multiplex RSV detection assay for difficult respiratory samples, using ultrasone waves and MNAzyme technology. J Clin Virol 2009 0.93
11 Metabolism of the anti-hepatitis C virus nucleoside beta-D-N4-hydroxycytidine in different liver cells. Antimicrob Agents Chemother 2004 0.85
12 Evaluation of a line probe assay for identification of hepatitis B virus precore variants in serum from chronic hepatitis B carriers. J Virol Methods 2003 0.83
13 Mechanism of antiviral activities of 3'-substituted L-nucleosides against 3TC-resistant HBV polymerase: a molecular modelling approach. Antivir Chem Chemother 2003 0.83
14 Targeted resequencing of HIV variants by microarray thermodynamics. Nucleic Acids Res 2013 0.80
15 Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains. Virology 2008 0.80
16 Synthesis and antiviral evaluation of 2',3'-dideoxy-2'-fluoro-3'- C-hydroxymethyl-beta-D-arabinofuranosyl pyrimidine nucleosides. Nucleosides Nucleotides Nucleic Acids 2003 0.79
17 N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activity. Antivir Chem Chemother 2003 0.77
18 Evaluation of a proximity extension assay for the detection of H1 2009 pandemic influenza viruses. J Virol Methods 2013 0.76
19 A label-free potentiometric sensor principle for the detection of antibody-antigen interactions. Anal Chem 2013 0.75
20 Synthesis and anti-HCV activity of N9,5'-cyclo-3-(beta-D-ribofuranosyl)-8-azapurin-2-one derivatives. Nucleosides Nucleotides Nucleic Acids 2005 0.75
21 Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents. Nucleosides Nucleotides Nucleic Acids 2007 0.75
22 Nosocomial transmission of hepatitis B virus associated with endomyocardial biopsy. Gastroenterol Clin Biol 2006 0.75